{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:32:43Z","timestamp":1787020363252,"version":"build-2736575974"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870825"],"award-info":[{"award-number":["81870825"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071194"],"award-info":[{"award-number":["82071194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Brain Initiative from Beijing Municipal Science & Technology Commission","award":["Z201100005520016"],"award-info":[{"award-number":["Z201100005520016"]}]},{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7202061"],"award-info":[{"award-number":["7202061"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The most common biomarkers of Alzheimer\u2019s disease (AD) are amyloid \u03b2 (A\u03b2) and tau, detected in cerebrospinal fluid (CSF) or with positron emission tomography imaging. However, these procedures are invasive and expensive, which hamper their availability to the general population. Here, we report a panel of microRNAs (miRNAs) in serum that can predict P-tau\/A\u03b242 in CSF and readily differentiate AD from other dementias, including vascular dementia (VaD), Parkinson disease dementia (PDD), behavioral variant frontotemporal dementia (bvFTD), and dementia with Lewy body (DLB).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>RNA samples were extracted from the participant\u2019s blood. P-tau\/A\u03b242 of CSF was examined for diagnostic purposes. A pilot study (controls, 21; AD, 23), followed by second (controls, 216; AD, 190) and third groups (controls, 153; AD, 151), is used to establish and verify a predictive model of P-tau\/A\u03b242 in CSF. The test is then applied to a fourth group of patients with different dementias (controls, 139; AD,155; amnestic mild cognitive impairment [aMCI], 55; VaD, 51; PDD, 53; bvFTD, 53; DLB, 52) to assess its diagnostic capacity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the pilot study, 29 upregulated and 31 downregulated miRNAs in the AD group were found. In Dataset 2, these miRNAs were then included as independent variables in the linear regression model. A seven-microRNA panel (miR-139-3p, miR-143-3p, miR-146a-5p, miR-485-5p, miR-10a-5P, miR-26b-5p, and miR-451a-5p) accurately predicted values of P-tau\/A\u03b242 of CSF. In Datasets 3 and 4, by applying the predicted P-tau\/A\u03b242, the predictive model successfully differentiates AD from controls and VaD, PDD, bvFTD, and DLB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study suggests that the panel of microRNAs is a promising substitute for traditional measurement of P-tau\/A\u03b242 in CSF as an effective biomarker of AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-021-02142-x","type":"journal-article","created":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T19:02:43Z","timestamp":1636916563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Prediction of P-tau\/A\u03b242 in the cerebrospinal fluid with blood microRNAs in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3648-3668","authenticated-orcid":false,"given":"Longfei","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qigeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"issue":"3","key":"2142_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):263\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"2142_CR2","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/archneurol.2008.596","volume":"66","author":"T Tapiola","year":"2009","unstructured":"Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, et al. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol. 2009;66(3):382\u20139. https:\/\/doi.org\/10.1001\/archneurol.2008.596.","journal-title":"Arch Neurol"},{"issue":"2","key":"2142_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2018.09.001","volume":"15","author":"R La Joie","year":"2019","unstructured":"La Joie R, Ayakta N, Seeley WW, Borys E, Boxer AL, DeCarli C, et al. Multisite study of the relationships between antemortem [(11)C]PIB-PET Centiloid values and postmortem measures of Alzheimer\u2019s disease neuropathology. Alzheimers Dement. 2019;15(2):205\u201316. https:\/\/doi.org\/10.1016\/j.jalz.2018.09.001.","journal-title":"Alzheimers Dement"},{"issue":"8","key":"2142_CR4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1001\/jamaneurol.2020.0989","volume":"77","author":"A Leuzy","year":"2020","unstructured":"Leuzy A, Smith R, Ossenkoppele R, Santillo A, Borroni E, Klein G, et al. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders. JAMA Neurol. 2020;77(8):955\u201365. https:\/\/doi.org\/10.1001\/jamaneurol.2020.0989.","journal-title":"JAMA Neurol"},{"issue":"7","key":"2142_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U, Ohrfelt A, Portelius E, Bjerke M, et al. CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol. 2016;15(7):673\u201384. https:\/\/doi.org\/10.1016\/S1474-4422(16)00070-3.","journal-title":"Lancet Neurol"},{"issue":"3","key":"2142_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","volume":"5","author":"O Hansson","year":"2006","unstructured":"Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 2006;5(3):228\u201334. https:\/\/doi.org\/10.1016\/S1474-4422(06)70355-6.","journal-title":"Lancet Neurol"},{"issue":"6","key":"2142_CR7","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1001\/jamaneurol.2018.0118","volume":"75","author":"A Lleo","year":"2018","unstructured":"Lleo A, Irwin DJ, Illan-Gala I, McMillan CT, Wolk DA, Lee EB, et al. A 2-step cerebrospinal algorithm for the selection of frontotemporal lobar degeneration subtypes. JAMA Neurol. 2018;75(6):738\u201345. https:\/\/doi.org\/10.1001\/jamaneurol.2018.0118.","journal-title":"JAMA Neurol"},{"issue":"11","key":"2142_CR8","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.jalz.2018.01.013","volume":"14","author":"SE Schindler","year":"2018","unstructured":"Schindler SE, Gray JD, Gordon BA, Xiong C, Batrla-Utermann R, Quan M, et al. Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging. Alzheimers Dement. 2018;14(11):1460\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2018.01.013.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"2142_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3233\/JAD-141725","volume":"44","author":"JL Seeburger","year":"2015","unstructured":"Seeburger JL, Holder DJ, Combrinck M, Joachim C, Laterza O, Tanen M, et al. Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer\u2019s disease from other dementias and healthy controls in the OPTIMA cohort. J Alzheimers Dis. 2015;44(2):525\u201339. https:\/\/doi.org\/10.3233\/JAD-141725.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"2142_CR10","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jalz.2019.05.002","volume":"15","author":"L Jia","year":"2019","unstructured":"Jia L, Qiu Q, Zhang H, Chu L, Du Y, Zhang J, et al. Concordance between the assessment of Abeta42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid. Alzheimers Dement. 2019;15(8):1071\u201380. https:\/\/doi.org\/10.1016\/j.jalz.2019.05.002.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2142_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/alz.12166","volume":"17","author":"L Jia","year":"2020","unstructured":"Jia L, Zhu M, Kong C, Pang Y, Zhang H, Qiu Q, et al. Blood neuro-exosomal synaptic proteins predict Alzheimer\u2019s disease at the asymptomatic stage. Alzheimers Dement. 2020;17(1):49\u201360. https:\/\/doi.org\/10.1002\/alz.12166.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"2142_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrm2868","volume":"11","author":"M Inui","year":"2010","unstructured":"Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010;11(4):252\u201363. https:\/\/doi.org\/10.1038\/nrm2868.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"2142_CR13","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.14336\/AD.2018.1105","volume":"10","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Zhang Y, Zhang L, Dong Y, Ji H, Shen L. The potential markers of circulating microRNAs and long non-coding RNAs in Alzheimer\u2019s disease. Aging Dis. 2019;10(6):1293\u2013301. https:\/\/doi.org\/10.14336\/AD.2018.1105.","journal-title":"Aging Dis"},{"issue":"7","key":"2142_CR14","doi-asserted-by":"publisher","first-page":"R78","DOI":"10.1186\/gb-2013-14-7-r78","volume":"14","author":"P Leidinger","year":"2013","unstructured":"Leidinger P, Backes C, Deutscher S, Schmitt K, Mueller SC, Frese K, et al. A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol. 2013;14(7):R78. https:\/\/doi.org\/10.1186\/gb-2013-14-7-r78.","journal-title":"Genome Biol"},{"key":"2142_CR15","doi-asserted-by":"publisher","first-page":"101732","DOI":"10.1016\/j.pneurobio.2019.101732","volume":"185","author":"MMJ van den Berg","year":"2020","unstructured":"van den Berg MMJ, Krauskopf J, Ramaekers JG, Kleinjans JCS, Prickaerts J, Briede JJ. Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders. Prog Neurobiol. 2020;185:101732. https:\/\/doi.org\/10.1016\/j.pneurobio.2019.101732.","journal-title":"Prog Neurobiol"},{"issue":"2","key":"2142_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","volume":"134","author":"A Kapasi","year":"2017","unstructured":"Kapasi A, DeCarli C, Schneider JA. Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol. 2017;134(2):171\u201386. https:\/\/doi.org\/10.1007\/s00401-017-1717-7.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"2142_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2142_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tibtech.2010.09.007","volume":"29","author":"C Humpel","year":"2011","unstructured":"Humpel C. Identifying and validating biomarkers for Alzheimer\u2019s disease. Trends Biotechnol. 2011;29(1):26\u201332. https:\/\/doi.org\/10.1016\/j.tibtech.2010.09.007.","journal-title":"Trends Biotechnol"},{"issue":"9518","key":"2142_CR19","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/S0140-6736(06)68542-5","volume":"367","author":"S Gauthier","year":"2006","unstructured":"Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, et al. Mild cognitive impairment. Lancet. 2006;367(9518):1262\u201370. https:\/\/doi.org\/10.1016\/S0140-6736(06)68542-5.","journal-title":"Lancet"},{"issue":"2","key":"2142_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1212\/WNL.43.2.250","volume":"43","author":"GC Roman","year":"1993","unstructured":"Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43(2):250\u201360. https:\/\/doi.org\/10.1212\/WNL.43.2.250.","journal-title":"Neurology"},{"issue":"Suppl 2","key":"2142_CR21","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1002\/ana.21455","volume":"64","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Emre M, Dubois B. Parkinson\u2019s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol. 2008;64(Suppl 2):S81\u201392. https:\/\/doi.org\/10.1002\/ana.21455.","journal-title":"Ann Neurol"},{"issue":"Pt 9","key":"2142_CR22","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(Pt 9):2456\u201377. https:\/\/doi.org\/10.1093\/brain\/awr179.","journal-title":"Brain"},{"issue":"1","key":"2142_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058.","journal-title":"Neurology"},{"issue":"Pt 9","key":"2142_CR24","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1093\/brain\/awv181","volume":"138","author":"T Skillback","year":"2015","unstructured":"Skillback T, Farahmand BY, Rosen C, Mattsson N, Nagga K, Kilander L, et al. Cerebrospinal fluid tau and amyloid-beta1-42 in patients with dementia. Brain. 2015;138(Pt 9):2716\u201331. https:\/\/doi.org\/10.1093\/brain\/awv181.","journal-title":"Brain"},{"issue":"1","key":"2142_CR25","doi-asserted-by":"publisher","first-page":"1643670","DOI":"10.1080\/20013078.2019.1643670","volume":"8","author":"L Min","year":"2019","unstructured":"Min L, Zhu S, Chen L, Liu X, Wei R, Zhao L, et al. Evaluation of circulating small extracellular vesicles derived miRNAs as biomarkers of early colon cancer: a comparison with plasma total miRNAs. J Extracell Vesicles. 2019;8(1):1643670. https:\/\/doi.org\/10.1080\/20013078.2019.1643670.","journal-title":"J Extracell Vesicles"},{"issue":"3","key":"2142_CR26","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","volume":"10","author":"B Langmead","year":"2009","unstructured":"Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10(3):R25. https:\/\/doi.org\/10.1186\/gb-2009-10-3-r25.","journal-title":"Genome Biol"},{"issue":"22","key":"2142_CR27","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1093\/bioinformatics\/btt509","volume":"29","author":"EP Nawrocki","year":"2013","unstructured":"Nawrocki EP, Eddy SR. Infernal 1.1: 100-fold faster RNA homology searches. Bioinformatics. 2013;29(22):2933\u20135. https:\/\/doi.org\/10.1093\/bioinformatics\/btt509.","journal-title":"Bioinformatics"},{"issue":"4","key":"2142_CR28","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nbt1394","volume":"26","author":"MR Friedlander","year":"2008","unstructured":"Friedlander MR, Chen W, Adamidi C, Maaskola J, Einspanier R, Knespel S, et al. Discovering microRNAs from deep sequencing data using miRDeep. Nat Biotechnol. 2008;26(4):407\u201315. https:\/\/doi.org\/10.1038\/nbt1394.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2142_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nmeth.1778","volume":"9","author":"T Kivioja","year":"2011","unstructured":"Kivioja T, Vaharautio A, Karlsson K, Bonke M, Enge M, Linnarsson S, et al. Counting absolute numbers of molecules using unique molecular identifiers. Nat Methods. 2011;9(1):72\u20134. https:\/\/doi.org\/10.1038\/nmeth.1778.","journal-title":"Nat Methods"},{"issue":"12","key":"2142_CR30","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"issue":"4","key":"2142_CR31","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"issue":"22","key":"2142_CR32","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","volume":"73","author":"CE Teunissen","year":"2009","unstructured":"Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009;73(22):1914\u201322. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c47cc2.","journal-title":"Neurology"},{"issue":"6","key":"2142_CR33","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4097\/kja.19087","volume":"72","author":"JH Kim","year":"2019","unstructured":"Kim JH. Multicollinearity and misleading statistical results. Korean J Anesthesiol. 2019;72(6):558\u201369. https:\/\/doi.org\/10.4097\/kja.19087.","journal-title":"Korean J Anesthesiol"},{"issue":"7691","key":"2142_CR34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Dore V, et al. High performance plasma amyloid-beta biomarkers for Alzheimer\u2019s disease. Nature. 2018;554(7691):249\u201354. https:\/\/doi.org\/10.1038\/nature25456.","journal-title":"Nature"},{"issue":"4","key":"2142_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jalz.2019.09.004","volume":"16","author":"FM Elahi","year":"2020","unstructured":"Elahi FM, Casaletto KB, La Joie R, Walters SM, Harvey D, Wolf A, et al. Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's disease. Alzheimers Dement. 2020;16(4):681\u201395. https:\/\/doi.org\/10.1016\/j.jalz.2019.09.004.","journal-title":"Alzheimers Dement"},{"key":"2142_CR36","doi-asserted-by":"crossref","unstructured":"Karikari TK, Emersic A, Vrillon A, Lantero-Rodriguez J, Ashton NJ, Kramberger MG, et al. Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer's disease diagnosis. Alzheimers Dement. 2020.","DOI":"10.1002\/alz.12236"},{"issue":"3","key":"2142_CR37","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ana.25172","volume":"83","author":"EJ Goetzl","year":"2018","unstructured":"Goetzl EJ, Schwartz JB, Abner EL, Jicha GA, Kapogiannis D. High complement levels in astrocyte-derived exosomes of Alzheimer disease. Ann Neurol. 2018;83(3):544\u201352. https:\/\/doi.org\/10.1002\/ana.25172.","journal-title":"Ann Neurol"},{"issue":"10","key":"2142_CR38","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1212\/WNL.0000000000007032","volume":"92","author":"J Kuhle","year":"2019","unstructured":"Kuhle J, Kropshofer H, Haering DA, Kundu U, Meinert R, Barro C, et al. Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology. 2019;92(10):e1007\u201315. https:\/\/doi.org\/10.1212\/WNL.0000000000007032.","journal-title":"Neurology"},{"issue":"12","key":"2142_CR39","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S1474-4422(19)30354-0","volume":"18","author":"EL van der Ende","year":"2019","unstructured":"van der Ende EL, Meeter LH, Poos JM, Panman JL, Jiskoot LC, Dopper EGP, et al. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study. Lancet Neurol. 2019;18(12):1103\u201311. https:\/\/doi.org\/10.1016\/S1474-4422(19)30354-0.","journal-title":"Lancet Neurol"},{"issue":"2","key":"2142_CR40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/jnnp-2018-318704","volume":"90","author":"F Verde","year":"2019","unstructured":"Verde F, Steinacker P, Weishaupt JH, Kassubek J, Oeckl P, Halbgebauer S, et al. Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90(2):157\u201364. https:\/\/doi.org\/10.1136\/jnnp-2018-318704.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"2142_CR41","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"TK Karikari","year":"2020","unstructured":"Karikari TK, Pascoal TA, Ashton NJ, Janelidze S, Benedet AL, Rodriguez JL, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 2020;19(5):422\u201333. https:\/\/doi.org\/10.1016\/S1474-4422(20)30071-5.","journal-title":"Lancet Neurol"},{"issue":"3","key":"2142_CR42","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.nbd.2008.11.009","volume":"33","author":"SS Hebert","year":"2009","unstructured":"Hebert SS, Horre K, Nicolai L, Bergmans B, Papadopoulou AS, Delacourte A, et al. MicroRNA regulation of Alzheimer\u2019s Amyloid precursor protein expression. Neurobiol Dis. 2009;33(3):422\u20138. https:\/\/doi.org\/10.1016\/j.nbd.2008.11.009.","journal-title":"Neurobiol Dis"},{"issue":"24","key":"2142_CR43","doi-asserted-by":"publisher","first-page":"18344","DOI":"10.1074\/jbc.M110.112664","volume":"285","author":"E Vilardo","year":"2010","unstructured":"Vilardo E, Barbato C, Ciotti M, Cogoni C, Ruberti F. MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J Biol Chem. 2010;285(24):18344\u201351. https:\/\/doi.org\/10.1074\/jbc.M110.112664.","journal-title":"J Biol Chem"},{"issue":"37","key":"2142_CR44","doi-asserted-by":"publisher","first-page":"31298","DOI":"10.1074\/jbc.M112.366336","volume":"287","author":"JM Long","year":"2012","unstructured":"Long JM, Ray B, Lahiri DK. MicroRNA-153 physiologically inhibits expression of amyloid-beta precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients. J Biol Chem. 2012;287(37):31298\u2013310. https:\/\/doi.org\/10.1074\/jbc.M112.366336.","journal-title":"J Biol Chem"},{"issue":"3","key":"2142_CR45","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.neurobiolaging.2010.04.034","volume":"33","author":"W Liu","year":"2012","unstructured":"Liu W, Liu C, Zhu J, Shu P, Yin B, Gong Y, et al. MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer\u2019s-associated pathogenesis in SAMP8 mice. Neurobiol Aging. 2012;33(3):522\u201334. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.04.034.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"2142_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3233\/JAD-170592","volume":"61","author":"PR Manzine","year":"2018","unstructured":"Manzine PR, Pelucchi S, Horst MA, Vale FAC, Pavarini SCI, Audano M, et al. microRNA 221 targets ADAM10 mRNA and is downregulated in Alzheimer\u2019s disease. J Alzheimers Dis. 2018;61(1):113\u201323. https:\/\/doi.org\/10.3233\/JAD-170592.","journal-title":"J Alzheimers Dis"},{"key":"2142_CR47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neurobiolaging.2017.11.007","volume":"63","author":"R Akhter","year":"2018","unstructured":"Akhter R, Shao Y, Shaw M, Formica S, Khrestian M, Leverenz JB, et al. Regulation of ADAM10 by miR-140-5p and potential relevance for Alzheimer\u2019s disease. Neurobiol Aging. 2018;63:110\u20139. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.11.007.","journal-title":"Neurobiol Aging"},{"issue":"17","key":"2142_CR48","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1073\/pnas.0710263105","volume":"105","author":"SS Hebert","year":"2008","unstructured":"Hebert SS, Horre K, Nicolai L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, et al. Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/beta-secretase expression. Proc Natl Acad Sci U S A. 2008;105(17):6415\u201320. https:\/\/doi.org\/10.1073\/pnas.0710263105.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2142_CR49","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","volume":"28","author":"WX Wang","year":"2008","unstructured":"Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, et al. The expression of microRNA miR-107 decreases early in Alzheimer\u2019s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci. 2008;28(5):1213\u201323. https:\/\/doi.org\/10.1523\/JNEUROSCI.5065-07.2008.","journal-title":"J Neurosci"},{"issue":"44","key":"2142_CR50","doi-asserted-by":"publisher","first-page":"14717","DOI":"10.1523\/JNEUROSCI.2053-15.2015","volume":"35","author":"J Kim","year":"2015","unstructured":"Kim J, Yoon H, Horie T, Burchett JM, Restivo JL, Rotllan N, et al. microRNA-33 regulates ApoE lipidation and amyloid-beta metabolism in the brain. J Neurosci. 2015;35(44):14717\u201326. https:\/\/doi.org\/10.1523\/JNEUROSCI.2053-15.2015.","journal-title":"J Neurosci"},{"key":"2142_CR51","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fnagi.2016.00140","volume":"8","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Jaber V, Lukiw WJ. Over-expressed pathogenic miRNAs in Alzheimer\u2019s disease (AD) and Prion disease (PrD) drive deficits in TREM2-mediated Abeta42 peptide clearance. Front Aging Neurosci. 2016;8:140. https:\/\/doi.org\/10.3389\/fnagi.2016.00140.","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"2142_CR52","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1002\/emmm.201201974","volume":"5","author":"P Lau","year":"2013","unstructured":"Lau P, Bossers K, Janky R, Salta E, Frigerio CS, Barbash S, et al. Alteration of the microRNA network during the progression of Alzheimer\u2019s disease. EMBO Mol Med. 2013;5(10):1613\u201334. https:\/\/doi.org\/10.1002\/emmm.201201974.","journal-title":"EMBO Mol Med"},{"issue":"Pt 3","key":"2142_CR53","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/brain\/awv383","volume":"139","author":"QB Zhu","year":"2016","unstructured":"Zhu QB, Unmehopa U, Bossers K, Hu YT, Verwer R, Balesar R, et al. MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer\u2019s disease. Brain. 2016;139(Pt 3):908\u201321. https:\/\/doi.org\/10.1093\/brain\/awv383.","journal-title":"Brain"},{"issue":"37","key":"2142_CR54","doi-asserted-by":"publisher","first-page":"14645","DOI":"10.1523\/JNEUROSCI.1327-13.2013","volume":"33","author":"S Absalon","year":"2013","unstructured":"Absalon S, Kochanek DM, Raghavan V, Krichevsky AM. MiR-26b, upregulated in Alzheimer\u2019s disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons. J Neurosci. 2013;33(37):14645\u201359. https:\/\/doi.org\/10.1523\/JNEUROSCI.1327-13.2013.","journal-title":"J Neurosci"},{"issue":"47","key":"2142_CR55","doi-asserted-by":"publisher","first-page":"12581","DOI":"10.1523\/JNEUROSCI.3338-08.2008","volume":"28","author":"A Aschrafi","year":"2008","unstructured":"Aschrafi A, Schwechter AD, Mameza MG, Natera-Naranjo O, Gioio AE, Kaplan BB. MicroRNA-338 regulates local cytochrome c oxidase IV mRNA levels and oxidative phosphorylation in the axons of sympathetic neurons. J Neurosci. 2008;28(47):12581\u201390. https:\/\/doi.org\/10.1523\/JNEUROSCI.3338-08.2008.","journal-title":"J Neurosci"},{"issue":"7239","key":"2142_CR56","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature07823","volume":"458","author":"P Gao","year":"2009","unstructured":"Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, et al. c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature. 2009;458(7239):762\u20135. https:\/\/doi.org\/10.1038\/nature07823.","journal-title":"Nature"},{"issue":"1","key":"2142_CR57","doi-asserted-by":"publisher","first-page":"e1000795","DOI":"10.1371\/journal.pgen.1000795","volume":"6","author":"J Li","year":"2010","unstructured":"Li J, Donath S, Li Y, Qin D, Prabhakar BS, Li P. miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway. PLoS Genet. 2010;6(1):e1000795. https:\/\/doi.org\/10.1371\/journal.pgen.1000795.","journal-title":"PLoS Genet"},{"issue":"1","key":"2142_CR58","doi-asserted-by":"publisher","first-page":"24566","DOI":"10.1038\/srep24566","volume":"6","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Liu C, Wang J, Li Q, Ping H, Gao S, et al. MiR-299-5p regulates apoptosis through autophagy in neurons and ameliorates cognitive capacity in APPswe\/PS1dE9 mice. Sci Rep. 2016;6(1):24566. https:\/\/doi.org\/10.1038\/srep24566.","journal-title":"Sci Rep"},{"key":"2142_CR59","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3389\/fphar.2017.00524","volume":"8","author":"J Sun","year":"2017","unstructured":"Sun J, Gao X, Meng D, Xu Y, Wang X, Gu X, et al. Antagomirs targeting miroRNA-134 attenuates epilepsy in rats through regulation of oxidative stress, mitochondrial functions and autophagy. Front Pharmacol. 2017;8:524. https:\/\/doi.org\/10.3389\/fphar.2017.00524.","journal-title":"Front Pharmacol"},{"issue":"27","key":"2142_CR60","doi-asserted-by":"publisher","first-page":"42274","DOI":"10.18632\/oncotarget.9786","volume":"7","author":"M Cheng","year":"2016","unstructured":"Cheng M, Liu L, Lao Y, Liao W, Liao M, Luo X, et al. MicroRNA-181a suppresses parkin-mediated mitophagy and sensitizes neuroblastoma cells to mitochondrial uncoupler-induced apoptosis. Oncotarget. 2016;7(27):42274\u201387. https:\/\/doi.org\/10.18632\/oncotarget.9786.","journal-title":"Oncotarget"},{"issue":"1","key":"2142_CR61","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-016-0121-4","volume":"11","author":"J Kim","year":"2016","unstructured":"Kim J, Fiesel FC, Belmonte KC, Hudec R, Wang WX, Kim C, et al. miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1). Mol Neurodegener. 2016;11(1):55. https:\/\/doi.org\/10.1186\/s13024-016-0121-4.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"2142_CR62","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nn.3935","volume":"18","author":"P Verma","year":"2015","unstructured":"Verma P, Augustine GJ, Ammar MR, Tashiro A, Cohen SM. A neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity. Nat Neurosci. 2015;18(3):379\u201385. https:\/\/doi.org\/10.1038\/nn.3935.","journal-title":"Nat Neurosci"},{"issue":"1","key":"2142_CR63","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1186\/s12864-016-3139-7","volume":"17","author":"VY Poon","year":"2016","unstructured":"Poon VY, Gu M, Ji F, VanDongen AM, Fivaz M. miR-27b shapes the presynaptic transcriptome and influences neurotransmission by silencing the polycomb group protein Bmi1. BMC Genomics. 2016;17(1):777. https:\/\/doi.org\/10.1186\/s12864-016-3139-7.","journal-title":"BMC Genomics"},{"key":"2142_CR64","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.conb.2017.02.014","volume":"45","author":"Z Hu","year":"2017","unstructured":"Hu Z, Li Z. miRNAs in synapse development and synaptic plasticity. Curr Opin Neurobiol. 2017;45:24\u201331. https:\/\/doi.org\/10.1016\/j.conb.2017.02.014.","journal-title":"Curr Opin Neurobiol"},{"issue":"11","key":"2142_CR65","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.jalz.2019.06.4952","volume":"15","author":"P Takousis","year":"2019","unstructured":"Takousis P, Sadlon A, Schulz J, Wohlers I, Dobricic V, Middleton L, et al. Differential expression of microRNAs in Alzheimer\u2019s disease brain, blood, and cerebrospinal fluid. Alzheimers Dement. 2019;15(11):1468\u201377. https:\/\/doi.org\/10.1016\/j.jalz.2019.06.4952.","journal-title":"Alzheimers Dement"},{"issue":"8","key":"2142_CR66","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.prp.2010.03.005","volume":"206","author":"I Barshack","year":"2010","unstructured":"Barshack I, Lithwick-Yanai G, Afek A, Rosenblatt K, Tabibian-Keissar H, Zepeniuk M, et al. MicroRNA expression differentiates between primary lung tumors and metastases to the lung. Pathol Res Pract. 2010;206(8):578\u201384. https:\/\/doi.org\/10.1016\/j.prp.2010.03.005.","journal-title":"Pathol Res Pract"},{"issue":"10","key":"2142_CR67","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1373\/clinchem.2008.109603","volume":"54","author":"AE Szafranska","year":"2008","unstructured":"Szafranska AE, Doleshal M, Edmunds HS, Gordon S, Luttges J, Munding JB, et al. Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin Chem. 2008;54(10):1716\u201324. https:\/\/doi.org\/10.1373\/clinchem.2008.109603.","journal-title":"Clin Chem"},{"issue":"7","key":"2142_CR68","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1093\/eurheartj\/ehw250","volume":"38","author":"M Karakas","year":"2017","unstructured":"Karakas M, Schulte C, Appelbaum S, Ojeda F, Lackner KJ, Munzel T, et al. Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study. Eur Heart J. 2017;38(7):516\u201323. https:\/\/doi.org\/10.1093\/eurheartj\/ehw250.","journal-title":"Eur Heart J"},{"issue":"12","key":"2142_CR69","doi-asserted-by":"publisher","first-page":"e0145930","DOI":"10.1371\/journal.pone.0145930","volume":"10","author":"C Schulte","year":"2015","unstructured":"Schulte C, Molz S, Appelbaum S, Karakas M, Ojeda F, Lau DM, et al. miRNA-197 and miRNA-223 predict cardiovascular death in a cohort of patients with symptomatic coronary artery disease. PLoS One. 2015;10(12):e0145930. https:\/\/doi.org\/10.1371\/journal.pone.0145930.","journal-title":"PLoS One"},{"issue":"6","key":"2142_CR70","doi-asserted-by":"publisher","first-page":"10567","DOI":"10.3390\/ijms150610567","volume":"15","author":"Y Liu","year":"2014","unstructured":"Liu Y, Gao G, Yang C, Zhou K, Shen B, Liang H, et al. The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. Int J Mol Sci. 2014;15(6):10567\u201377. https:\/\/doi.org\/10.3390\/ijms150610567.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2142_CR71","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00592-014-0617-8","volume":"51","author":"Z Yang","year":"2014","unstructured":"Yang Z, Chen H, Si H, Li X, Ding X, Sheng Q, et al. Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes. Acta Diabetol. 2014;51(5):823\u201331. https:\/\/doi.org\/10.1007\/s00592-014-0617-8.","journal-title":"Acta Diabetol"},{"issue":"2","key":"2142_CR72","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3233\/JAD-161179","volume":"57","author":"J Riancho","year":"2017","unstructured":"Riancho J, Vazquez-Higuera JL, Pozueta A, Lage C, Kazimierczak M, Bravo M, et al. MicroRNA profile in patients with Alzheimer\u2019s disease: analysis of miR-9-5p and miR-598 in raw and exosome enriched cerebrospinal fluid samples. J Alzheimers Dis. 2017;57(2):483\u201391. https:\/\/doi.org\/10.3233\/JAD-161179.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"2142_CR73","doi-asserted-by":"publisher","first-page":"e0126423","DOI":"10.1371\/journal.pone.0126423","volume":"10","author":"J Denk","year":"2015","unstructured":"Denk J, Boelmans K, Siegismund C, Lassner D, Arlt S, Jahn H. MicroRNA profiling of CSF reveals potential biomarkers to detect Alzheimer\u2019s disease. PLoS One. 2015;10(5):e0126423. https:\/\/doi.org\/10.1371\/journal.pone.0126423.","journal-title":"PLoS One"},{"key":"2142_CR74","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.arr.2018.10.008","volume":"49","author":"S Nagaraj","year":"2019","unstructured":"Nagaraj S, Zoltowska KM, Laskowska-Kaszub K, Wojda U. microRNA diagnostic panel for Alzheimer\u2019s disease and epigenetic trade-off between neurodegeneration and cancer. Ageing Res Rev. 2019;49:125\u201343. https:\/\/doi.org\/10.1016\/j.arr.2018.10.008.","journal-title":"Ageing Res Rev"},{"issue":"5","key":"2142_CR75","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jalz.2015.12.012","volume":"12","author":"A Keller","year":"2016","unstructured":"Keller A, Backes C, Haas J, Leidinger P, Maetzler W, Deuschle C, et al. Validating Alzheimer\u2019s disease micro RNAs using next-generation sequencing. Alzheimers Dement. 2016;12(5):565\u201376. https:\/\/doi.org\/10.1016\/j.jalz.2015.12.012.","journal-title":"Alzheimers Dement"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02142-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-021-02142-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02142-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T19:03:01Z","timestamp":1636916581000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-021-02142-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2142"],"URL":"https:\/\/doi.org\/10.1186\/s12916-021-02142-x","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]},"assertion":[{"value":"7 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants or their legal guardians. This study was approved by the Institutional Ethics Board of Xuanwu Hospital, Capital Medical University (LYS[2017]004).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"264"}}